Beacon NewsFlashes – October 8, 2009

Nobel Prize Winners – Elizabeth Blackburn, Carol Greider, and Jack Szostak received the Nobel Prize in medicine for discovering an enzyme called telomerase. The telomerase enzyme is responsible for repairing the ends of chromosomes, which lead to cancer and aging when damaged. Since its discovery, telomerase has been researched extensively for treatment of many cancers, including multiple myeloma. Many treatments and applications using telomerase are currently in clinical trials. For more information, please visit the Examiner Web site.
Managing Myeloma: An Expert’s Update – On October 29, from noon to 1:30 p.m. ET, the Leukemia & Lymphoma Society (LLS) is holding a free telephone conference focusing on managing myeloma. The speaker for the conference is Dr. Kenneth Anderson, a key opinion leader in myeloma. This is a great opportunity to speak with Dr. Anderson during the Q&A session. For more information or to register, please visit the LLS Web site.
For a more detailed listing of myeloma related events, please check the Myeloma Beacon Events Calendar.
Related Articles:
- Latest Myeloma Research To Be Presented At The American Society Of Clinical Oncology Annual Meeting (ASCO 2018)
- Importance Of Factors Affecting Multiple Myeloma Survival Changes With Patient Age
- Stem Cell Transplantation May Be Underutilized In Multiple Myeloma Patients In Their 80s
- Number And Type Of Stem Cell Transplants Carried Out Each Year For Multiple Myeloma Vary Markedly Across U.S. Cancer Centers
- Nelfinavir-Velcade Combination Very Active In Advanced, Velcade-Resistant Multiple Myeloma